Skip to Content

Sandostatin

In the US, Sandostatin (octreotide systemic) is a member of the drug class somatostatin and somatostatin analogs and is used to treat Acromegaly, Carcinoid Tumor and Vasoactive Intestinal Peptide Tumor.

US matches:

UK matches:

Ingredient matches for Sandostatin

Octreotide

Octreotide is reported as an ingredient of Sandostatin in the following countries:

  • Argentina
  • Austria
  • Bosnia & Herzegowina
  • Brazil
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • Georgia
  • Greece
  • Hong Kong
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Malta
  • Norway
  • Romania
  • South Africa
  • South Korea
  • Taiwan
  • Turkey
  • Vietnam

Octreotide acetate (a derivative of Octreotide) is reported as an ingredient of Sandostatin in the following countries:

  • Australia
  • Bulgaria
  • Canada
  • Chile
  • China
  • Estonia
  • Finland
  • Germany
  • Hungary
  • Ireland
  • Japan
  • Latvia
  • Lithuania
  • New Zealand
  • Oman
  • Philippines
  • Poland
  • Serbia
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide